Literature DB >> 9697826

Androgen receptors mediate hypertrophy in cardiac myocytes.

J D Marsh1, M H Lehmann, R H Ritchie, J K Gwathmey, G E Green, R J Schiebinger.   

Abstract

BACKGROUND: The role of androgens in producing cardiac hypertrophy by direct action on cardiac myocytes is uncertain. Accordingly, we tested the hypothesis that cardiac myocytes in adult men and women express an androgen receptor gene and that myocytes respond to androgens by a hypertrophic response. METHODS AND
RESULTS: We used reverse transcription-polymerase chain reaction methods to demonstrate androgen receptor transcripts in multiple tissues and [3H]phenylalanine incorporation and atrial natriuretic peptide secretion as markers of hypertrophy in cultured rat myocytes. Messenger RNA encoding androgen receptors was detected in myocytes of male and female adult rats, neonatal rat myocytes, rat heart, dog heart, and infant and adult human heart. Both testosterone and dihydrotestosterone produced a robust receptor-specific hypertrophic response in myocytes, determined by indices of protein synthesis and atrial natriuretic peptide secretion.
CONCLUSIONS: Androgen receptors are present in cardiac myocytes from multiple species, including normal men and women, in a context that permits androgens to modulate the cardiac phenotype and produce hypertrophy by direct, receptor-specific mechanisms. There are clinical implications for therapeutic or illicit use of androgens in humans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9697826     DOI: 10.1161/01.cir.98.3.256

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  94 in total

1.  Influence of dynamic gap junction resistance on impulse propagation in ventricular myocardium: a computer simulation study.

Authors:  A P Henriquez; R Vogel; B J Muller-Borer; C S Henriquez; R Weingart; W E Cascio
Journal:  Biophys J       Date:  2001-10       Impact factor: 4.033

2.  FHL2, a novel tissue-specific coactivator of the androgen receptor.

Authors:  J M Müller; U Isele; E Metzger; A Rempel; M Moser; A Pscherer; T Breyer; C Holubarsch; R Buettner; R Schüle
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

Review 3.  Sex is a potent modifier of the cardiovascular system.

Authors:  Leslie A Leinwand
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

4.  Androgen receptor counteracts Doxorubicin-induced cardiotoxicity in male mice.

Authors:  Yasumasa Ikeda; Ken-ichi Aihara; Masashi Akaike; Takashi Sato; Kazue Ishikawa; Takayuki Ise; Shusuke Yagi; Takashi Iwase; Yuka Ueda; Sumiko Yoshida; Hiroyuki Azuma; Kenneth Walsh; Toshiaki Tamaki; Shigeaki Kato; Toshio Matsumoto
Journal:  Mol Endocrinol       Date:  2010-05-25

5.  Variable expression of nuclear receptor coactivator 4 (NcoA4) during mouse embryonic development.

Authors:  Alexandra Kollara; Theodore J Brown
Journal:  J Histochem Cytochem       Date:  2010-03-30       Impact factor: 2.479

Review 6.  Differences between ventricular repolarization in men and women: description, mechanism and implications.

Authors:  Borys Surawicz; Sanjay R Parikh
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-10       Impact factor: 1.468

7.  Comparison of electrocardiographic repolarization patterns between hypogonad males and normal subjects.

Authors:  Ata Kirilmaz; Erol Bolu; Fethi Kilicaslan; Kursad Erinc; Mehmet Uzun; Ersoy Isik; Metin Ozata; Caglayan Ozdemir; Ertan Demirtas
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-10       Impact factor: 1.468

8.  Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?

Authors:  A Urhausen; T Albers; W Kindermann
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

9.  Anabolic androgenic steroid-induced acute myocardial infarction with multiorgan failure.

Authors:  Frederick J Flo; Obiajulu Kanu; Mohamed Teleb; Yuefeng Chen; Tariq Siddiqui
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-05-15

10.  Testosterone protects rat hearts against ischaemic insults by enhancing the effects of alpha(1)-adrenoceptor stimulation.

Authors:  S Tsang; S Wu; J Liu; T M Wong
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.